Regulation 2
The Cosmetic Products (Safety) Regulations 1996f1 are amended as follows–
in Schedule 1–
by the insertion after entry number 136 of the following–
“
136A 1-tert-Butyl-3,4,5-trimethyl-2,6-dinitrobenzene 489A 422 ”;
by the insertion after entry number 488 of the following–
“
488A Moskene 543A 421 ”;
by the insertion after entry number 489 of the following–
“
489A Musk tibetene 136A 422 ”;
by the insertion after entry number 543 of the following–
“
543A 1,1,3,3,5,-Pentamethyl-4,6-dinitroindane 488A 421 ”;
in Part I of Schedule 2 by the substitution for entry number 57 of the following–
“
57 Strontium chloride hexahydrate (a) Toothpaste 3.5 per cent calculated as strontium. When mixed with other permitted strontium compounds the total strontium content must not exceed 3.5 per cent. — Contains strontium chloride. Frequent use by children is not advisable. (b) Shampoo and face care products 2.1 per cent calculated as strontium. When mixed with other permitted strontium compounds the total strontium content must not exceed 2.1 per cent. — – ”;
in Part I of Schedule 4, by adding the following entry after entry number 53–
“
54 Benzalkonium chloride, bromide and saccharinate All products 0.1 per cent calculated as benzalkonium chloride A — Avoid contact with the eyes ”;
in Part II of Schedule 4–
by the deletion of entry number 16;
in entry number 21 by the substitution for “30.6.1998” of “30.6.1999”;
by the substitution for entry number 29 of the following–
“
29 3-Iodoprop-2-ynyl butylcarbamate [Iodopropynyl butylcarbamate] Not to be used in oral hygiene and lip products 0.05 per cent — — 30.06.1999 ”;
in Part I of Schedule 5–
by adding the following entries after entry number 12–
“
13 Ethoxylated ethyl-4-aminobenzoate 10 per cent – – [PEG-25 PABA] 14 Isopentyl 4-methoxycinnamate 10 per cent – – [Isoamyl p-methoxycinnamate] 15 Tris(2-ethylhexyl) 4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate 5 per cent – – [Octyl triazone] ”;
by adding the following after new entry 15–
“
16 2-(2H-Benzotriazol-2-yl)-4-methyl-6-{2-methyl-3-[1,3,3,3-tetramethyl-1-(trimethylsilyloxy)-disiloxan-1-yl]propyl}phenol [Drometrizole trisiloxane] 15 per cent – – 17 Bis(2-ethylhexyl) 4,4'-[6-(tert-butylcarbamoylanilino)-1,3,5-triazine-2,4-diyldiimino]dibenzoate 10 per cent – – ”;
by adding the following after new entry 17–
“
18 3-(4-Methylbenzyl-idene)bornan-2-one [4-Methylbenzylidene camphor] 4 per cent – – 19 3-Benzylidenebornan-2-one [3-Benzylidene camphor] 2 per cent – – 20 2-Ethylhexyl salicylate [Octyl salicylate] 5 per cent – – ”; and
in Part II of Schedule 5–
by deleting entry numbers 2, 6, 12, 25, 26 and 32 and substituting the words “ENTRY DELETED”; and
by the substitution for “30.6.1998” in entry numbers 5, 17 and 29 of “30.6.1999”.